PDCD1 and neoplasm: Similarly, some chemotherapeutic agents induced PD-1 on NK cells, and higher expression levels of PD-L1 on tumor cells were described after exposure to both chemotherapy and radiotherapy, suggesting that combining these therapies with PD-1-PD-L1 blockade might enhance NK cell activity [38,80,81].